Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015
Blood Adv
.
2017 Sep 22;1(21):1839-1841.
doi: 10.1182/bloodadvances.2017011031.
eCollection 2017 Sep 26.
Authors
Avinash G Dinmohamed
1
2
3
,
Djamila E Issa
4
,
Marjolein W M van der Poel
5
,
Harry C Schouten
5
,
Pieternella J Lugtenburg
3
,
Martine E D Chamuleau
6
,
Sonja Zweegman
6
,
Otto Visser
7
Affiliations
1
Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
2
Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
3
Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
4
Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
5
Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
6
Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands; and.
7
Department of Registration, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
PMID:
29297513
PMCID:
PMC5728101
DOI:
10.1182/bloodadvances.2017011031
No abstract available
Publication types
Comment